Pharmacology of Favimol

 Favipiravir (T-705) is an engineered prodrug, first found while evaluating the antiviral action of substance specialists dynamic against the flu infection in the compound library of Toyoma synthetics. A lead compound, A/PR/8/34, later assigned as T-1105, and its subordinates were found to have antiviral exercises. Favipiravir is determined by synthetic alteration of the pyrazine moiety of T-1105 (Fig. 1).2 It has been affirmed in Japan for the administration of arising pandemic flu contaminations in 2014.





Comments

Popular posts from this blog

What is Molupiravir?

What is Avigan?